Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Nanobac Pharmaceuticals, Incorporated NNBP OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
16/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Analyst Consensus — NNBP

No analyst consensus data available for NNBP.

People Also View

ASCLF
ASCLF
Ascletis Pharma Inc.
$2.10
+0.00%
 MOLN
MOLN
Molecular Partners AG
$4.20
+1.45%
 CYT
CYT
Cyteir Therapeutics, Inc.
$3.02
-2.27%
 CSBR
CSBR
Champions Oncology, Inc.
$6.18
+7.85%
 AVTE
AVTE
Aerovate Therapeutics, Inc.
$2.68
+0.00%
 MNOV
MNOV
MediciNova, Inc.
$1.43
+1.42%
 ANEB
ANEB
Anebulo Pharmaceuticals, Inc.
$0.50
+0.00%
 SILO
SILO
Silo Pharma, Inc.
$0.41
+2.38%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message